This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Insulin » Inhaled Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Is Inhaled Insulin Still Safe After 2 Years?

Posted: Thursday, May 03, 2007

The safety of inhaled insulin is holding up at 2 years in an ongoing study, with adverse pulmonary effects being small, occurring early, and proving reversible on cessation of the drug.

Uncontrolled Type 2 Diabetes Patients More Likely to Start Insulin When Inhaled Insulin Is an Option

Posted: Wednesday, April 25, 2007

The availability of inhaled insulin may increase the number of patients with uncontrolled type 2 diabetes who are willing to start or intensify insulin therapy.

MannKind Corporation Will Submit for FDA Approval for It’s SUPRA Inhaled Insulin

Posted: Thursday, February 08, 2007

It has been described by Jay Skyler, a leading diabetologist, as the first in a new class of diabetic therapies, "Supra-Rapid Acting Insulin’s", that can change the way diabetes is treated.

Nasal Insulin Expands Trial for Postpranidal Hyperglycemia Indication

Posted: Thursday, December 07, 2006

Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley's human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Exubera Slow to Catch On

Posted: Thursday, December 07, 2006

Jury is still out on Exubera. Diabetics are holding their breath, and that may not be good news for the Pfizer, the world's biggest drugmaker. It's been nearly a year since the FDA approved Exubera, the first inhalable form of insulin for diabetics. Some analysts hail the device as a potential blockbuster, but Exubera doesn't appear to have caught on.

Nasal Insulin Spray Moving Forward with Phase 2 Trials

Posted: Thursday, November 30, 2006

Two earlier studies conducted in Ireland with normal subjects and Type I diabetic patients demonstrated rapid absorption from the nasal spray and the expected glucose response.

Inhalable Insulin May Be A ‘Flop'

Posted: Thursday, November 02, 2006

Inhalable insulin is unlikely to achieve the blockbuster status the industry had hoped for, according to a new report.

New DPP-4 and Glitazone Diabetes Drugs Will Account for 72% of the Diabetes Mark

Posted: Thursday, October 05, 2006

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

Snuff It or Puff It: Rapid Acting Insulin Nasal Spray Begins New Study

Posted: Thursday, September 28, 2006

A new pharmacokinetic study to compare Nastech's intranasal insulin to injectable insulin and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder, is set to begin.

Exubera Works Even with Cold or Flu-Study

Posted: Thursday, September 21, 2006

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.